Literature DB >> 8345349

Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation.

M Harris1, K Coates.   

Abstract

The human immunodeficiency virus (HIV) type 1 nef gene product was expressed as an N-terminal fusion protein with glutathione-S-transferase (GST) in the baculovirus system. The resulting nefGST fusion protein was found to be authentically myristylated at the N terminus and could be purified to homogeneity by one-step affinity chromatography on immobilized glutathione. The high affinity of nefGST for glutathione was exploited to develop an assay to identify cellular proteins capable of interacting with nef. Several such proteins were identified in extracts from the Jurkat human T cell line. The interaction between nef-binding proteins and immobilized nefGST could be specifically competed by the addition of soluble nef. Cell fractionation showed that nef-binding proteins were present in both cytosolic and membrane-associated fractions. A non-myristylated derivative failed to bind to the membrane-associated proteins but was able to bind to the cytosolic group, albeit with reduced affinity. In addition, a single protein present in both soluble and membrane-associated fractions exhibited myristylation-independent binding to nef. By analogy with other myristylated proteins such as MARCKS (myristylated alanine-rich C kinase substrate) and the Rous sarcoma virus transforming protein, src, the membrane-associated proteins that bind only to myristylated nef may represent a specific membrane target for nef. The cytosolic proteins that interact with nef may constitute soluble components of an as yet unidentified signal transduction pathway which is the target of nef action in the HIV-1-infected cell.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345349     DOI: 10.1099/0022-1317-74-8-1581

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Molecular biology of the human immunodeficiency virus accessory proteins.

Authors:  R A Subbramanian; E A Cohen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

2.  Nef inhibits glucose uptake in adipocytes and contributes to insulin resistance in human immunodeficiency virus type I infection.

Authors:  Laura Cheney; June C Hou; Sidonie Morrison; Jeffrey Pessin; Roy T Steigbigel
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

3.  Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain.

Authors:  A Preusser; L Briese; A S Baur; D Willbold
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family.

Authors:  M F Nunn; J W Marsh
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes.

Authors:  E T Sawai; A Baur; H Struble; B M Peterlin; J A Levy; C Cheng-Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs.

Authors:  James R Boyne; Brian R Jackson; Adam Taylor; Stuart A Macnab; Adrian Whitehouse
Journal:  EMBO J       Date:  2010-04-30       Impact factor: 11.598

7.  Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines.

Authors:  A Greenway; A Azad; D McPhee
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Identification of a novel phosphorylation site in hepatitis C virus NS5A.

Authors:  Anna Nordle Gilliver; Stephen Griffin; Mark Harris
Journal:  J Gen Virol       Date:  2010-06-30       Impact factor: 3.891

9.  A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly.

Authors:  Mair Hughes; Sarah Gretton; Holly Shelton; David D Brown; Christopher J McCormick; Allan G N Angus; Arvind H Patel; Stephen Griffin; Mark Harris
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.